New strategies in cardiovascular disease management: summary of round table discussion Bühler, Fritz R.; Cohn, Jay N.; Hermsmeyer, Kent; More Bühler, Fritz R.; Cohn, Jay N.; Hermsmeyer, Kent; Ménard, Joël; Abernethy, Darrell R.; Kobrin, Isaac; Pratt, Craig M. Less Journal of Hypertension. 15(3):S1-S3, 1997. Favorite PDF Permissions Buy
Novel concepts in Ca2+ channel selectivity Hermsmeyer, Kent; Miyagawa, Koichi Hermsmeyer, Kent; Miyagawa, Koichi Less Journal of Hypertension. 15(3):S5-S10, 1997. Abstract Abstract Favorite PDF Permissions Buy
Pharmacology of the calcium antagonist mibefradil Lüscher, Thomas F.; Clozel, Jean-Paul; Noll, Georg Lüscher, Thomas F.; Clozel, Jean-Paul; Noll, Georg Less Journal of Hypertension. 15(3):S11-S18, 1997. Abstract Abstract Favorite PDF Permissions Buy
Effects of calcium blockade on end-organ damage in experimental hypertension Ménard, Joël; Karam, Habib; Véniant, Murielle; More Ménard, Joël; Karam, Habib; Véniant, Murielle; Heudes, Didier; Bruneval, Patrick; Clozel, Jean-Paul Less Journal of Hypertension. 15(3):S19-S30, 1997. Abstract Abstract Favorite PDF Permissions Buy
Optimized pharmacokinetic and pharmacodynamic profiles in cardiovascular disease therapy Abernethy, Darrell R. Abernethy, Darrell R. Less Journal of Hypertension. 15(3):S31-S33, 1997. Abstract Abstract Favorite PDF Permissions Buy
Predictable clinical effects in the treatment of hypertension and chronic, stable angina pectoris: clinical studies of mibefradil Kobrin, Isaac; Charlon, Vincent Kobrin, Isaac; Charlon, Vincent Less Journal of Hypertension. 15(3):S35-S40, 1997. Abstract Abstract Favorite PDF Permissions Buy
A personal view of the controversy regarding the use of calcium channel blockers in hypertension Pratt, Craig M. Pratt, Craig M. Less Journal of Hypertension. 15(3):S41-S46, 1997. Abstract Abstract Favorite PDF Permissions Buy
